Abstract:Prader-Willi syndrome (PWS) is a complex imprinting disorder related to genomic errors that inactivate paternally-inherited genes on chromosome 15q11-q13 with severe implications on endocrine, cognitive and neurologic systems, metabolism, and behavior. The absence of expression of one or more genes at the PWS critical region contributes to different phenotypes. There are three molecular mechanisms of occurrence: paternal deletion of the 15q11-q13 region; maternal uniparental disomy 15; or imprinting defects. Although there is a clinical diagnostic consensus criteria, DNA methylation status must be confirmed through genetic testing. The endocrine system can be the most affected in PWS, and growth hormone replacement therapy provides improvement in growth, body composition, and behavioral and physical attributes. A key feature of the syndrome is the hypothalamic dysfunction that may be the basis of several endocrine symptoms. Clinical and molecular complexity in PWS enhances the importance of genetic diagnosis in therapeutic definition and genetic counseling. So far, no single gene mutation has been described to contribute to this genetic disorder or related to any exclusive symptoms. Here we proposed to review individually disrupted genes within the PWS critical region and their reported clinical phenotypes related to the syndrome. While genes such as MKRN3, MAGEL2, NDN, or SNORD115 do not address the full spectrum of PWS symptoms and are less likely to have causal implications in PWS major clinical signs, SNORD116 has emerged as a critical, and possibly, a determinant candidate in PWS, in the recent years. Besides that, the understanding of the biology of the PWS SNORD genes is fairly low at the present. These non-coding RNAs exhibit all the hallmarks of RNA methylation guides and can be incorporated into ribonucleoprotein complexes with possible hypothalamic and endocrine functions. Also, DNA conservation between SNORD sequences across placental mammals strongly suggests that they have a functional role as RNA entities on an evolutionary basis. The broad clinical spectrum observed in PWS and the absence of a clear genotype-phenotype specific correlation imply that the numerous genes involved in the syndrome have an additive deleterious effect on different phenotypes when deficiently expressed.

Investigating the correlation between genotype and phenotype in Prader-Willi syndrome: a study of 45 cases from Brazil

Genotype-Phenotype Relationships and Endocrine Findings in Prader-Willi Syndrome

Clinical and Molecular Characterization of Prader-Willi Syndrome

The Diagnosis and Genetic Mechanisms of Prader-Willi Syndrome: Findings From a Moroccan Population Study

A rapid and accurate methylation‐sensitive high‐resolution melting analysis assay for the diagnosis of Prader Willi and Angelman patients

Clinical and genetic analysis for four Chinese families with Prader–Willi syndrome

Prader-willi syndrome:a clinical and epigenetic study of 4 cases

Clinical and epigenetic study of a case of Prader-Willi syndrome

Genotype–phenotype correlation in Prader‐Willi syndrome: A large‐sample analysis in China

The Genotype and Phenotype Correlation of Prader-Willi Syndrome

Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation

Genotype and Phenotype in Patients with Prader-Willi Syndrome in Taiwan

Relationship between phenotype and genotype of 102 Chinese newborns with Prader–Willi syndrome

Prader-Willi Syndrome: Molecular Mechanism and Epigenetic Therapy

Psychotic illness in people with Prader–Willi syndrome: a systematic review of clinical presentation, course and phenomenology

Characterization of Circulating Protein Profiles in Individuals with Prader–Willi Syndrome and Individuals with Non-Syndromic Obesity

Microglial phagolysosome dysfunction and altered neural communication amplify phenotypic severity in Prader-Willi Syndrome with larger deletion

Clinical and Genetic Features of Prader-Willi Syndrome in China

Oral disorders in children with Prader-Willi syndrome: a case control study

Establishing Perinatal and Neonatal Features of Prader-Willi Syndrome for Efficient Diagnosis and Outcomes

Metabolomic profiling of Prader-Willi syndrome compared with essential obesity